KLRS smart money

Kalaris Therapeutics, INC. (KLRS): 2 insider buys, 2 top funds holding it in the public filings.

Insider buys, 12 months$6.2M

Insider buys

FiledWhoRoleAmountPrice
2026-05-22Samsara Biocapital, L.P.TenPercentOwner$1.2M$4.83
2026-02-17Samsara Opportunity Fund, L.P.TenPercentOwner$5.0M$10.42

Top 100 funds holding it

#FundChangeWeightValue
50Siren, L.L.C.TRIM -18%0.02%$1M
86Adar1 Capital Management, LLCTRIM -40%0.01%$200k
Open the live smart money map